Users will be able to choose between two different kits: the Everlywell nasal swab kit for $109, or the Vault Health saliva kit for $119, both of which can provide results in 24 hours. The option will be available in 12 cities initially: Baltimore, Chicago, Cleveland, Denver, Minneapolis, Phoenix and Dallas, with more locations intended in the future.
“COVID-19 testing will continue to play a critical role as businesses and schools begin to re-open across the U.S.,” DoorDash said in a press release. “Tests that can be taken at home and mailed to a lab offer even more convenience to customers as they eliminate the need to make a trip to a testing facility, or wait in long lines at the pharmacy or grocery store.”